Winter Quarter Our Gen31 experiment assays the transgenic Tau Alzheimer’s Disease (AD) flies and our “B” flies with MX100a, memantine (Namenda), and combinations of the two therapies. Memantine (Namenda), is one of only a few “first line” therapies used to treat AD. Genescient made the decision to test memantine using our fly model to validate […]